Image credit: mi_viri / Shutterstock. Boston-based Paratek Pharmaceuticals has released positive topline data from a Phase IIb trial evaluating its oral antibiotic Nuzyra (omadacycline) in adult ...

INDIANAPOLIS--(BUSINESS WIRE)--#clinicaltrial--MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b ...

Clinical Trials Arena · mi_viri / Shutterstock. Boston-based Paratek Pharmaceuticals has released positive topline data from a Phase IIb trial evaluating its oral antibiotic Nuzyra (omadacycline ...

The Phase 2b VOYAGE study of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH; also referred to as metabolic dysfunction associated steatohepatitis, MASH) and fibrosis ...

NEW TAIPEI CITY, Oct. 23, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) completed CBL-514 Phase 2b study for non-surgical fat reduction (CBL-0205, clinicaltrials.gov ID: NCT06005441) on ...

INDIANAPOLIS — GeniPhys, a preclinical-stage company developing regenerative collagen polymeric biomaterials for soft tissue restoration, has been awarded a $500,000 National Science Foundation (NSF) ...

Conducted across 34 sites in the US, the trial enrolled 301 adults with MDD. Credit: Suriyawut Suriya/Shutterstock. Alto Neuroscience (Alto) has reported that its Phase IIb clinical trial of ALTO-100 ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Alto Neuroscience (Alto) has reported that its Phase IIb clinical trial of ALTO-100 for treating major depressive disorder (MDD) failed to meet its primary endpoint. The study aimed to assess ALTO ...

The company has reported promising data from its Phase 2b trial of Descartes-08, an mRNA-based CAR-T cell therapy, in treating generalized myasthenia gravis. This data highlights the treatment’s ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2024. Today, Nov. 16, 2024, the moon is 15 days old and is in the Full Moon phase of its lunar cycle.

(“Alto”) (NYSE: ANRO), a clinical stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that the Phase 2b ...